ITGAM and neoplasm: We sorted TAMs (CD11b+F4/80+) from LLC tumors after control or ONP-302 treatment and examined gene expression patterns associated with the pro-inflammatory/anti-tumor M1 and anti- inflammatory/pro-tumor M2 types of TAMs.